Allan C. deCamp

Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 30 papers. Top paper: “Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition”.

Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition

New England Journal of Medicine(2021)10.1056/nejmoa2031738

N/A

6.2DataRank · unranked

547 citations

Peter B. Gilbert, Michal Juraska, David C. Montefiori, Lynn Morris, Shelly Karuna +40 more

Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial

Nature Medicine(2021)10.1038/s41591-021-01509-0

N/A

2.3DataRank · unranked

104 citations

Boris Jülg, Chen Sabrina Tan, Rebecca Zash, Stephen R. Walsh, Charlotte-Paige Rolle +35 more

A first-in-human germline-targeting HIV nanoparticle vaccine induced broad and publicly targeted helper T cell responses

Science Translational Medicine(2023)10.1126/scitranslmed.adf3309

N/A

1.4DataRank · unranked

75 citations

Stephen C. De Rosa, William J. Fulp, Allan C. deCamp, Andrew Fioré-Gartland, Celia R. Mahoney +26 more

Phase 1 Human Immunodeficiency Virus (HIV) Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Subtype C DNA and MF59-Adjuvanted Subtype C Envelope Protein

Clinical Infectious Diseases(2020)10.1093/cid/ciz1239

N/A

1.2DataRank · unranked

35 citations

Craig Innes, Sarita Naidoo, Philipp Mann, Julia Hütter, Gita Ramjee +69 more

HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen

Science(2016)10.1126/science.aad9195

N/A

0.929DataRank · unranked

487 citations

Daniel W. Kulp, Colin Havenar-Daughton, Anita Sarkar, Bryan Briney, Devin Sok +17 more

Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition

Nature Medicine(2022)10.1038/s41591-022-01953-6

N/A

0.731DataRank · unranked

130 citations

Yunda Huang, Allan C. deCamp, Shelly Karuna, Yuanyuan Zhang, Craig A. Magaret +42 more

High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials

Nature Communications(2023)10.1038/s41467-023-43384-y

N/A

0.515DataRank · unranked

22 citations

Bryan T. Mayer, Allan C. deCamp, Yunda Huang, Bo Zhang, Lindsay N. Carpp +28 more

Protein Dose-Sparing Effect of AS01B Adjuvant in a Randomized Preventive HIV Vaccine Trial of ALVAC-HIV (vCP2438) and Adjuvanted Bivalent Subtype C gp120

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad434

N/A

0.395DataRank · unranked

7 citations

Fatima Laher, One Dintwe, Monde Muyoyeta, Allan C. deCamp, Zonglin He +27 more

Focusing HIV-1 Gag T cell responses to highly conserved regions by DNA vaccination in HVTN 119

JCI Insight(2024)10.1172/jci.insight.180819

N/A

0.356DataRank · unranked

8 citations

Barbara K. Felber, James I. Mullins, Hyman Scott, Mary Allen, Stephen C. De Rosa +14 more

Resistance mutations that distinguish HIV-1 envelopes with discordant VRC01 phenotypes from multi-lineage infections in the HVTN703/HPTN081 trial: implications for cross-resistance

Journal of Virology(2025)10.1128/jvi.01730-24

N/A

0.331DataRank · unranked

7 citations

Bronwen E. Lambson, Nonhlanhla N. Mkhize, Chivonne Moodley, Anna Yssel, Thandeka Moyo-Gwete +16 more

Prediction of serum HIV-1 neutralization titers of VRC01 in HIV-uninfected Antibody Mediated Prevention (AMP) trial participants

UNC Libraries(2023)10.17615/q13b-q658

N/A

0DataRank · unranked

0 citations

Srilatha Edupuganti, Shelly Karuna, Michal Juraska, Nonhlanhla N. Mkhize, P. Andrew +16 more

Pharmacokinetics and predicted neutralisation coverage of VRC01 in HIV-uninfected participants of the Antibody Mediated Prevention (AMP) trials

UNC Libraries(2023)10.17615/f8gd-ra57

N/A

0DataRank · unranked

0 citations

Paula González, Kathryn Mngadi, John R. Mascola, L. Naidoo, Peter B. Gilbert +18 more

Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features

Proceedings of the National Academy of Sciences(2024)10.1073/pnas.2308942121

N/A

0DataRank · unranked

21 citations

Hongjun Bai, Allan C. deCamp, Craig A. Magaret, Li Li, Kevin Gillespie +37 more

Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features

Nature Communications(2024)10.1038/s41467-024-46536-w

N/A

0DataRank · unranked

12 citations

Li Li, Allan C. deCamp, Morgane Rolland, Michal Juraska, Brian D. Williamson +45 more

Rare twin cysteine residues in the HIV-1 envelope variable region 1 link to neutralization escape and breadth development

Cell Host & Microbe(2025)10.1016/j.chom.2025.01.004

N/A

0DataRank · unranked

3 citations

Marius Zeeb, Peter Rusert, Chloé Pasin, Jennifer L. Mamrosh, Samuel Mundia Kariuki +33 more

A Pentavalent HIV-1 Subtype C Vaccine Containing Computationally Selected gp120 Strains Improves the Breadth of V1V2 Region Responses

Vaccines(2025)10.3390/vaccines13020133

N/A

0DataRank · unranked

3 citations

Bette Korber, Rachel L. Spreng, Sheetal Sawant, Allan C. deCamp, Arthur S. McMillan +12 more

Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.07.01.659979

N/A

0DataRank · unranked

1 citations

Chivonne Moodley, Craig A. Magaret, Elena Giorgi, Morgane Rolland, Dylan H. Westfall +43 more

VRC01 Selects Rare HIV Escape Mutations After Acquisition in Antibody-Mediated Prevention Trials

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.10.29.685411

N/A

0DataRank · unranked

1 citations

Lyle Curry, Nonhlanhla N. Mkhize, Elena Giorgi, Craig A. Magaret, Bronwen E. Lambson +44 more

Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features

Carolina Digital Repository (University of North Carolina at Chapel Hill)(2025)10.17615/t225-p023

N/A

0DataRank · unranked

0 citations

Hong Zhao, Lennie Chen, Li Li, Wenjie Deng, Tanmoy Bhattacharya +37 more

Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition

UNC Libraries(2025)10.17615/19xw-z883

N/A

0DataRank · unranked

0 citations

José A. Hidalgo, Fatima Laher, John Hural, Nicole L. Yates, Caroline Brackett +40 more

Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition

UNC Libraries(2023)10.17615/5a1m-e268

N/A

0DataRank · unranked

0 citations

Wang Yao Feng, D.C. Montefiori, Haajira Kaldine, Valerie Bekker, Georgia D. Tomaras +41 more

Pharmacokinetics and predicted neutralisation coverage of VRC01 in HIV-uninfected participants of the Antibody Mediated Prevention (AMP) trials

EBioMedicine(2021)10.1016/j.ebiom.2020.103203

N/A

0DataRank · unranked

29 citations

Logashvari Naidoo, Lily Zhang, Lindsay N. Carpp, Erika Rudnicki, April K. Randhawa +18 more

Comprehensive Data Integration Approach to Assess Immune Responses and Correlates of RTS,S/AS01-Mediated Protection From Malaria Infection in Controlled Human Malaria Infection Trials

Frontiers in Big Data(2021)10.3389/fdata.2021.672460

N/A

0DataRank · unranked

20 citations

Lindsay N. Carpp, Sidhartha Chaudhury, Jason A. Regules, Elke S. Bergmann‐Leitner, Christian F. Ockenhouse +20 more

Selection of HIV Envelope Strains for Standardized Assessments of Vaccine-Elicited Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies

Journal of Virology(2021)10.1128/jvi.01643-21

N/A

0DataRank · unranked

14 citations

Sherry Stanfield-Oakley, Bhavesh Borate, Leigh H. Fisher, Katelyn Faircloth, Marina Tuyishime +12 more

Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections

UNC Libraries(2021)10.17615/pr2z-dq66

N/A

0DataRank · unranked

3 citations

Jesus F. Salazar-Gonzalez, Tongye Shen, Craig A. Magaret, William R. Schief, Brian Gaschen +27 more

Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials

PLoS Pathogens(2023)10.1371/journal.ppat.1011469

N/A

0DataRank · unranked

56 citations

Anna Yssel, Haajira Kaldine, Rebecca T. van Dorsten, Amanda S. Woodward Davis, Nicolas Beaume +35 more

Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition

EBioMedicine(2023)10.1016/j.ebiom.2023.104590

N/A

0DataRank · unranked

33 citations

Yunda Huang, Shelly Karuna, Jack Heptinstall, Caroline Brackett, Kelvin Chiong +40 more

Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features

Research Square(2023)10.21203/rs.3.rs-2743022/v1

N/A

0DataRank · unranked

0 citations

Li Li, Allan C. deCamp, Morgane Rolland, Michal Juraska, Brian D. Williamson +38 more

Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials

UNC Libraries(2023)10.17615/nx73-wv26

N/A

0DataRank · unranked

0 citations

John Hural, Ruwayhida Thebus, Amanda Eaton, Shelly Karuna, Myron S. Cohen +35 more

Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials

PLoS Medicine(2020)10.1371/journal.pmed.1003117

N/A

0DataRank · unranked

14 citations

Stephen R. Walsh, Fatima Laher, Lucas Maganga, Michael E. Herce, Sarita Naidoo +28 more